Effect of Micosin vaginal cream compared to Miconazole vaginal cream for the treatment of mycotic vaginitis

Phase 2

• Conditions: candidiasis vaginitis.; Candidiasis of vulva and vagina; B37.3+

• Registration Number: IRCT2013120715697N1
• Lead Sponsor: Vice chancellor for Research; Islamic Azad University of Rasht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

women with Symptoms of Candida vaginitis infection in reproductive age.
Exclusion criteria: any history of taking antibiotics or immunosuppressive drugs or vaginal medications during the four weeks prior to the start of the study; diagnosis with cervicitis; suffering from candida vaginitis for more than 3 times a year; pelvic inflammatory disease; pregnancy or menopause; patients with high risk conditions (such as diabetes, anemia, obesity, overt autoimmune disease, coagulation disorders); history of allergic reaction to garlic or cream of vaginal azole class; improper application of the medication; refusal to pay follow-up visits; personal decision by patients not to participate in the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of candidiasis vaginitis signs. Timepoint: One week after treatment. Method of measurement: cheak list; examination; wet mount; fungial culture.